✦ LIBER ✦
Clinical outcomes with a recombinant follicle-stimulating hormone (rFSH)/gonadotropin-releasing hormone (GnRH) antagonist regimen are unaffected by rFSH dose tapering, coasting or 24 hour hCG delay
✍ Scribed by S.C. Pang; A. Leader; H. Witjes; M. Mahony; K. Gordon
- Book ID
- 116477731
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 62 KB
- Volume
- 94
- Category
- Article
- ISSN
- 1556-5653
No coin nor oath required. For personal study only.